Key Takeaways & Executive Findings
- •• Aquatic exercise significantly improves muscle strength in healthy older adults (SMD=0.56, 95%CI 0.39-0.74). • Optimal dose: 2-3 sessions per week, 40 minutes per session, moderate-to-vigorous intensity (Borg RPE 10-12), for at least 24 weeks. • Training period, frequency, and weekly total duration show cumulative effects, while session duration and intensity follow an inverted U-shaped relationship. • Bayesian dose-response meta-analysis provides precise quantification of nonlinear dose-response relationships, guiding personalized exercise prescription.
Abstract
OBJECTIVE: To systematically evaluate and quantify the effects of different doses of aquatic exercise on muscle strength in healthy older adults using a Bayesian model-based dose-response meta-analysis, thereby determining the optimal exercise regimen and providing evidence-based recommendations for precise exercise prescription. METHODS: A systematic search was conducted in both English and Chinese databases, including PubMed, Embase, Web of Science, CNKI, and WanFang, to identify randomized controlled trials published up to March 2025 that investigated the effects of aquatic exercise on muscle strength in older adults. Data analysis was performed using R 4.5.0. A conventional meta-analysis was first conducted to estimate the overall effect, followed by a Bayesian model-based dose-response meta-analysis to quantify the nonlinear relationships between different exercise dose dimensions (frequency, session duration, weekly total duration, period, and intensity) and muscle strength improvement. The standardized mean difference (SMD) with 95% confidence interval (CI) was used as the effect size. RESULTS: A total of 13 randomized controlled trials involving 531 participants were included. The overall meta-analysis showed that aquatic exercise significantly improved muscle strength in older adults compared with control (SMD=0.56, 95%CI 0.39-0.74, P < 0.0001). Dose-response analysis revealed cumulative trends for training period, frequency, and weekly total duration: the effect peaked at 24 weeks (SMD=0.65, 95%CI 0.40-0.66); significant gains were achieved at a frequency of twice per week (SMD=0.56, 95%CI 0.22-0.58), with a slight increase at three times (SMD=0.62, 95%CI 0.24-0.62); weekly cumulative duration showed significant effects at 100 minutes (SMD=0.58, 95%CI 0.34-0.60) and plateaued after 200 minutes. In contrast, session duration and intensity exhibited an inverted U-shaped relationship: the effect peaked at 40 minutes per session (SMD=0.62, 95%CI 0.32-0.82), with an optimal range of 30-45 minutes; the optimal intensity was Borg RPE 10-12 (SMD=0.45, 95%CI 0.18-0.46), with diminishing returns beyond this range. CONCLUSION: Aquatic exercise is an effective strategy for improving muscle strength in healthy older adults. It is recommended that older adults engage in aquatic exercise two to three times per week, with each session lasting approximately 40 minutes, at a moderate-to-vigorous intensity (Borg RPE 10-12), and as a long-term strategy.
1. Introduction
Muscle strength decline can affect the health, independent living ability, and quality of life of the elderly population [1]. With aging, muscle strength deteriorates, affecting bone support and internal organ function [2], forming a vicious cycle of 'muscle loss → reduced activity → further muscle loss' [3]. Muscle mass decreases by 1%-2% per year in people over 60 years old [4], which is a major cause of muscle strength decline.
Among intervention strategies to counteract age-related physical decline, regular physical exercise as a non-pharmacological intervention has been well-validated by evidence-based medicine. Existing studies show that systematic exercise training can significantly improve multiple functional indicators in the elderly through dual mechanisms of neuromuscular adaptation and metabolic regulation, such as balance, agility, cardiorespiratory endurance, and muscle strength [5]. Aquatic exercise stands out as an effective strategy for improving muscle strength among various exercises [6-8]. As a low mechanical stress exercise mode, aquatic exercise is an effective low-impact workout for the elderly. The buoyancy of water significantly offsets body weight load, thereby reducing compressive stress on joints and muscles, lowering the risk of exercise, and improving health [9]. Due to the physical properties of water, its density is 800 times higher than air, and it has viscosity, so moving in water encounters greater resistance than on land, requiring more muscle strength and forcing muscle groups to produce greater concentric contractions [10]. Moreover, compared with land, water is also a safe place for low-intensity exercise [11], and even elderly individuals who are too frail to exercise safely and effectively on land may benefit. The more supportive and effective environment in water may also positively improve exercise adherence [12]. However, research results on changing muscle strength in the elderly through aquatic exercise remain controversial in the literature.
Multiple trials have confirmed that aquatic training can improve muscle strength in the elderly. High-intensity aquatic exercise programs can effectively enhance upper and lower limb strength in elderly women [13]. Evidence from several systematic reviews and meta-analyses indicates that aquatic exercise can improve muscle strength in both young and elderly individuals [14], lower blood pressure [15-16], and increase maximal oxygen uptake [17]. Using assistive devices during exercise to increase resistance and control resistance can yield maximal strength gains in the elderly [18]; however, in the same study, when training movements were not resistance-controlled, the maximal shoulder flexion strength did not significantly improve.
Loading authentic research manuscript (Pages 1–5)...
WANG Yifei, ZHAO Jing, GAO Mingchen, WU Xiaobin (2026). Different doses of aquatic exercise for improving muscle strength in older adults: a meta-analysis. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21503
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the optimal dose of aquatic exercise for improving muscle strength in older adults?
The optimal dose is 2-3 sessions per week, each lasting about 40 minutes (optimal range 30-45 minutes), at a moderate-to-vigorous intensity (Borg RPE 10-12), and should be continued as a long-term strategy (at least 24 weeks).
How does the dose-response relationship of aquatic exercise affect muscle strength?
Training period, frequency, and weekly total duration show cumulative effects, with peak effects at 24 weeks, 2-3 times per week, and 100-200 minutes per week. In contrast, session duration and intensity follow an inverted U-shaped relationship, with optimal effects at 40 minutes per session and Borg RPE 10-12.
Is aquatic exercise effective for improving muscle strength in older adults?
Yes, the meta-analysis showed a significant overall effect (SMD=0.56, 95%CI 0.39-0.74, P < 0.0001), indicating that aquatic exercise significantly improves muscle strength in healthy older adults compared with control.
What are the limitations of this meta-analysis?
The study focused on healthy older adults, so results may not generalize to those with chronic conditions. There was heterogeneity in outcome measures, and long-term effects beyond 24 weeks and adherence mechanisms require further investigation.
How was the Bayesian dose-response meta-analysis conducted?
A Bayesian model-based dose-response meta-analysis was performed using R 4.5.0 to quantify nonlinear relationships between exercise dose dimensions and muscle strength improvement, allowing for precise estimation of optimal dose ranges.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.